Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2006Cancer ResearchOpen Access

Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYan ZhaoCentral Hospital of ZiboHTHuw D. ThomasDrug Discovery Laboratory (Norway)MBMichael A. BateyPerceptive Engineering (United Kingdom)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhao et al. (2006) studied this question.

synapsesocial.com/papers/6a0cecbc9b3db5752b0ce45fhttps://doi.org/10.1158/0008-5472.can-05-4275
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening1990 · 9,831 citations
  2. 2Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach2005 · 173 citations
  3. 3Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells2002 · 25 citations
  4. 4Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle2003 · 1,194 citations